MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/jcm14228156

Медицинская библиотека · Journal of clinical medicine · 2025

Epidemiological Study of Lymphedema Prevalence and Comorbidities in Hospitalized Patients in the United States.

Gérard Nicolas, Farmakis Ioannis T, Valerio Luca, Hobohm Lukas, Keller Karsten, Kucher Nils, Barco Stefano, Grigorean Alexandru

СтатьяПеревод пока не подготовлен

Аннотация

Background/

Objective

Lymphedema is a disabling condition that is both underdiagnosed and undertreated. Epidemiological data on this disease is sparse.

Methods

The prevalence of lymphedema was studied in hospitalized patients registered in the Nationwide Inpatient Sample (NIS) of the United States (US) from 2016 to 2020. ICD-10 codes related to lymphedema were utilized to identify eligible cases. We studied comorbidity burden and outcomes during hospitalizations, including in-hospital fatality, length of stay and total charges per hospitalization.

Results

Lymphedema was present in 0.45% (n = 792,475) of all hospitalizations; with prevalence increasing from 0.40% in 2016 to 0.50% in 2020. Lymphedema-mentioning hospitalizations peaked in July. The median age was 67 (IQR: 57-77) years; A total of 60% were female. Most lymphedema-mentioning hospitalizations were emergency admissions (90%). The most frequent comorbidities were arterial hypertension (77%), obesity (58%), diabetes mellitus (42%), phlegmon (38%), renal disease (32%), chronic pulmonary disease (31%), and cancer (26%). The in-hospital fatality rate was 2.3%, the median length of stay was 5 (IQR: 3-8) days, and each hospitalization incurred a median of 36,304 (IQR: 20,431, 67,171) US dollars, roughly three times higher than the average hospitalization costs in the NIS in the same period.

Conclusions

This represents the first comprehensive nationwide study of the epidemiological and economic burden of lymphedema among hospitalized patients in the US. The findings highlight that lymphedema, although underdiagnosed, affects a significant number of patients and is associated with a considerable burden of both comorbidities and costs.

Для цитирования: Gérard Nicolas, Farmakis Ioannis T, Valerio Luca, Hobohm Lukas, Keller Karsten, Kucher Nils, Barco Stefano, Grigorean Alexandru. Epidemiological Study of Lymphedema Prevalence and Comorbidities in Hospitalized Patients in the United States.. Journal of clinical medicine. 2025. DOI: 10.3390/jcm14228156.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.